Note: Ingredients listed on restricted chemical lists
EC/CAS
108-95-2
Name of the chemical
Phenol
Concentration
0-0.1
EC/CAS
1314-13-2
Name of the chemical
Zinc oxide; C.I. 77947
Concentration
0.001-0.004
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
96-98
General Information
Revision date
2010-04-19
Product name
HUMALOG
Substance name
000004271422
Product Synonyms
Insulin, Lispro
Chemical name
Insulin (human), 28B-L-lysine-29B-L-proline- Alternate Chemical Name Lys(B28), Pro(B29) human insulin analog
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
Eli Lilly and Company
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Lilly Lab Labeling Code Health: 0 Fire: 0 Reactivity: 0 Primary Hazards: Hormonal Hazard Summary (Caution) Effects of exposure may include Decreased blood sugar levels Emergency Overview Form liquid Colour colourless Odour odourless
Potential health effects
Ingestion Not expected to be active orally. Inhalation Effects of exposure to contents: Decreased blood sugar levels.
Medical Conditions Generally Aggravated by Exposure
Hypersensitivity to this product.
Principle Routes of Exposure
Inhalation Skin contact
Additional information
Decreased blood sugar levels. Symptoms typically associated with low blood sugar may include shakiness, sweating, fatigue, hunger, irritability, confusion, and rapid heartbeat. Carcinogenicity NTP No component of this product present at levels greater than or equal to 0.1% is identified as a known or anticipated carcinogen by NTP. IARC No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC. OSHA No component of this product present at levels greater than or equal to 0.1% is identified as a carcinogen or potential carcinogen by OSHA.
